Strides gets tentative USFDA nod for Dolutegravir tablets EP News Bureau Sep 15, 2023 The PEPFAR tentative approval for Strides qualifies the Company to participate in global donor funded programs that procure this…
Strides gets USFDA approval for Mycophenolate Mofetil for Oral Suspension EP News Bureau Aug 30, 2023 The products will be manufactured at the company’s facility in Bengaluru
Slowing trend of ANDA approvals in 2021: Pandemic effect or selective filings? EP News Bureau Feb 9, 2022 Meenu Grover Sharma, Principal Consultant, BusinessAssociar Consultants, New Delhi and Dr Professor Harvinder Popli, Director,…
Strides gets USFDA nod for Ibuprofen OTC Oral Suspension EP News Bureau Feb 24, 2021 Approval to strengthen company’s private label portfolio for the US market